Novartis Partners with Generate in $1B Biotech Deal
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
- Latest
- Trending
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
Biotech firms restructure with layoffs as FDA approves new drugs, exemplifying industry challenges and opportunities.
23andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
Personalis sees 35% Q2 revenue growth, lifts full-year outlook to $79-$81M.
Atticus Wealth Management LLC buys stake in Moleculin Biotech as the firm sets a “sell” rating on the stock; MBRX ...
A study warns that declining air quality in the US could cost companies and employees billions by 2050s. Climate change ...
Carle Health Methodist Hospital uses cutting-edge technology to detect lung cancer early, improving patient outcomes and saving lives. #LungCancerDetection
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.